Companies like SCIO have been leading the charge in creating compact, cloud-connected NIRS devices that provide instant readings, helping users gather actionable data. Read...
Read MoreBeckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, today announced expansion of their host immune response diagnostics partnership. Beckman Coulter is now an authorized distributor of the MeMed BV® assay, a rapid immunoassay test able to distinguish between bacterial and viral infections, and MeMed Key®, a compact immunoassay analyzer cleared to run the MeMed BV assay in the United States and Europe. This new distribution agreement complements the existing joint effort to develop a MeMed BV-based test for Beckman Coulter’s family of Access Immunoassay Analyzers. Read more...
Read MoreFrom artificial intelligence to telehealth, startups from all corners of the world are churning out innovative and game-changing technology, businesses and solutions. Historically, getting access to these startups as an investor has proven difficult unless you are an insider or have the backing of an institution. That has been changing thanks to companies like OurCrowd. The leading global digital investment firm has not only leveled the playing field for investors but flipped VCS investing on its head. Read more...
Read MoreComprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Scarlet Fu, Carol Massar and Tim Stenovec. David Westin speaks with Jon Medved, CEO and Founder of OurCrowd (Source: Bloomberg) Read more...
Read MoreAI seems to be the world’s fastest-growing investment sector. The rush of interest in ChatGPT and similar generative AI platforms has triggered a global wave of funding for the new technology. Read more...
Read More
